相关实验视频
Updated: Jan 18, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
区域贫困指数与黑色素瘤阶段在演示时之间的关联
Rachael Cowan1, Elizabeth Baker2, Mohammad Saleem3
1UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Cancers
|September 13, 2025
概括
通过区域贫困指数 (ADI) 衡量的邻里处境不利,与晚期黑色素瘤诊断有关. 这凸显了针对性干预的必要性,以解决弱势群体的差异.
科学领域:
- 皮肤病学 皮肤病学
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 晚期黑色素瘤诊断与较高的死亡率相关.
- 诸如获得医疗保健,社会经济地位和社区特征等因素会影响黑色素瘤在诊断时的阶段.
- 区域贫困指数 (ADI) 是评估邻里处于不利地位的一个关键指标.
研究的目的:
- 为了调查邻居的劣势之间的关联,通过ADI量化,和晚期黑色素瘤诊断的可能性.
- 了解社区层面的因素如何导致黑色素瘤呈现的差异.
- 为了确定具有晚期黑色素瘤风险较高的特定人群.
主要方法:
- 在2010年至2019年期间诊断出941名黑色素瘤患者的回顾性队列上进行了横截面分析.
- 患者的住所地址被地理编码,并与ADI和农村数据联系起来.
- 采用多变量逻辑回归模型,在人口普查系统层面聚类强大的标准错误,分析诊断时与黑色素瘤阶段的关联,并根据种族,种族,年龄,性别和保险状况等共变量进行调整.
主要成果:
- 在941名患者中,近一半 (46%) 被诊断为晚期黑色素瘤.
- 诊断为晚期黑色素瘤的患者与诊断为早期黑色素瘤的患者相比,平均ADI显著更高 (5.4比3.3,p<0.001).
- 在对ADI进行调整后,在黑色素瘤阶段测定中观察到的种族差异减弱了,这表明ADI在这些差异中发挥了重要作用.
结论:
- 邻里处于不利地位,正如较高的ADI得分所表明的那样,是晚期黑色素瘤诊断的重要预测因素.
- 这些发现强调了社区不利因素在恶化黑色素瘤的种族和社会经济差异中的作用.
- 有针对性的公共卫生倡议和教育干预措施对于减少弱势和脆弱人群中晚期黑色素瘤诊断至关重要.
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650

